Savara enters loan and security agreement with Hercules Capital

Savara ( NASDAQ: SVRA ) has entered into a loan and security agreement with Hercules Capital ( NYSE: HTGC ), for up to $200M. Access to the additional capital strengthens Savara’s balance sheet following the submission of the Biologics License Application to the U.S.

Food and Drug Administration (FDA) for.